Nurtec ODT 75 MG tablet 8S
Ended Awarded
- Contract number
- SPE2DR26F8ZEA
- Awardee
-
Amerisourcebergen Drug Corp UEI KABZK8W6PQT3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $30,457
Award facts
- Contract value 100% obligated
- $30,457.41 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Conshohocken, PA 19428, USA
Award details come from SAM.gov/FPDS.
About this award
AmerisourceBergen Drug Corp was awarded a delivery order contract valued at $30,457.41 by the Defense Logistics Agency (DLA) on November 6, 2025, for the supply of NURTEC ODT 75 mg tablets (eight-count packages). This firm fixed-price delivery order represents a non-set-aside competitive award and is performing out of the contractor's corporate office in Conshohocken, Pennsylvania. The award falls under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999.99 million prime vendor agreement extending through December 2026 that enables the company to supply a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.
NURTEC ODT is a migraine treatment medication used by the military healthcare system to support service members and beneficiaries. AmerisourceBergen Drug Corp, a major pharmaceutical distributor and critical federal vendor, maintains an extensive portfolio of federal contract awards with DLA covering diverse therapeutic domains including neurological treatments, pain management, diabetes medications, and specialized medical supplies. The company's demonstrated capability to meet federal procurement requirements through open competition, combined with its strategic role as a pharmaceutical prime vendor, positions it as a key supplier for the Defense Health Agency and other government healthcare systems requiring reliable pharmaceutical supply chain support.
Quick answers
Who was awarded contract SPE2DR26F8ZEA?
SPE2DR26F8ZEA was awarded to Amerisourcebergen Drug Corp by Defense Logistics Agency (Department of Defense) on November 6, 2025.
How much is contract SPE2DR26F8ZEA worth?
The government has obligated $30,457 on SPE2DR26F8ZEA.
Is contract SPE2DR26F8ZEA an order under another contract?
Yes. SPE2DR26F8ZEA is a delivery order under SPE2DR25D1017, an indefinite delivery contract.
Was contract SPE2DR26F8ZEA competed?
The extent of competition for SPE2DR26F8ZEA was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award